Free Trial
NASDAQ:ALMS

Alumis (ALMS) Stock Price, News & Analysis

Alumis logo
$4.51 +0.39 (+9.47%)
Closing price 04:00 PM Eastern
Extended Trading
$4.54 +0.03 (+0.55%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alumis Stock (NASDAQ:ALMS)

Advanced

Key Stats

Today's Range
$4.08
$4.53
50-Day Range
$3.95
$4.92
52-Week Range
$2.76
$13.11
Volume
1.73 million shs
Average Volume
544,950 shs
Market Capitalization
$469.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.17
Consensus Rating
Moderate Buy

Company Overview

Alumis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

ALMS MarketRank™: 

Alumis scored higher than 72% of companies evaluated by MarketBeat, and ranked 283rd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alumis has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 7 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Alumis has a consensus price target of $20.17, representing about 347.2% upside from its current price of $4.51.

  • Amount of Analyst Coverage

    Alumis has only been the subject of 4 research reports in the past 90 days.

  • Read more about Alumis' stock forecast and price target.
  • Earnings Growth

    Earnings for Alumis are expected to grow in the coming year, from ($8.51) to ($4.19) per share.

  • Price to Book Value per Share Ratio

    Alumis has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Alumis' valuation and earnings.
  • Percentage of Shares Shorted

    3.53% of the float of Alumis has been sold short.
  • Short Interest Ratio / Days to Cover

    Alumis has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alumis has recently increased by 16.18%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Alumis does not currently pay a dividend.

  • Dividend Growth

    Alumis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.53% of the float of Alumis has been sold short.
  • Short Interest Ratio / Days to Cover

    Alumis has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alumis has recently increased by 16.18%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Alumis has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Alumis this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for ALMS on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Alumis to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alumis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.70% of the stock of Alumis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Alumis' insider trading history.
Receive ALMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alumis and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALMS Stock News Headlines

Brokerages Set Alumis Inc. (NASDAQ:ALMS) PT at $20.17
Positive Signs As Multiple Insiders Buy Alumis Stock
Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
Alumis Inc. Updates Corporate Presentation on Pipeline
See More Headlines

ALMS Stock Analysis - Frequently Asked Questions

Alumis' stock was trading at $7.86 on January 1st, 2025. Since then, ALMS stock has decreased by 42.6% and is now trading at $4.51.

Alumis Inc. (NASDAQ:ALMS) issued its quarterly earnings data on Wednesday, August, 13th. The company reported ($1.17) earnings per share for the quarter, missing analysts' consensus estimates of ($1.11) by $0.06. The firm had revenue of $2.67 million for the quarter, compared to analyst estimates of $1.80 million.

Alumis (ALMS) raised $210 million in an initial public offering (IPO) on Friday, June 28th 2024. The company issued 13,125,000 shares at a price of $16.00 per share.

Shares of ALMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alumis investors own include Ashford Hospitality Trust (AHT), Artificial Intelligence Technology Solutions (AITX), Allakos (ALLK), BioXcel Therapeutics (BTAI), Clearside Biomedical (CLSD) and Delcath Systems (DCTH).

Company Calendar

Last Earnings
8/13/2025
Today
10/07/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALMS
Previous Symbol
NASDAQ:ALMS
CIK
1847367
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$14.00
Potential Upside/Downside
+347.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$294.23 million
Net Margins
N/A
Pretax Margin
-1,177.16%
Return on Equity
-119.15%
Return on Assets
-92.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.05
Quick Ratio
6.05

Sales & Book Value

Annual Sales
$20.06 million
Price / Sales
23.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.51 per share
Price / Book
0.82

Miscellaneous

Outstanding Shares
104,064,000
Free Float
61,710,000
Market Cap
$469.33 million
Optionable
N/A
Beta
-1.47
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ALMS) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners